We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants
COEPW

Delisted

COEPW was delisted on the 24th of April, 2026.

Back to rankings

27 hedge funds and large institutions have $1.03M invested in Coeptis Therapeutics Warrants in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 3

42% more funds holding

Funds holding: 19 → 27 (+8)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

10% less capital invested

Capital invested by funds: $1.15M → $1.03M (-$118K)

Holders
27
Holders Change
+8
Holders Change %
+42.11%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
2
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MC
Meteora Capital
Florida
+$29.2K
2
HF
HRT Financial
New York
+$7.52K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.57K
4
LCM
Landscape Capital Management
New Jersey
+$2.61K
5
Walleye Capital
Walleye Capital
New York
+$1.6K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$49K
2
ICMH
Integrity Capital Management (HK)
Hong Kong
-$4K
3
VF
Virtu Financial
New York
-$2K
4
SM
Skaana Management
New York
-$376
5
Wells Fargo
Wells Fargo
California
-$8
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$755K – – –
BFM
2
Boothbay Fund Management
New York
$151K – – –
ICM
3
Ionic Capital Management
New York
$20K – – –
MC
4
Meteora Capital
Florida
$18K +$29.2K +388,443 New
BCM
5
Basso Capital Management
Connecticut
$17K – – –
KC
6
Kepos Capital
New York
$12K – – –
OCAM
7
Owl Creek Asset Management
New York
$7K – – –
Wells Fargo
8
Wells Fargo
California
$6K -$8 -100 -0.1%
AA
9
AQR Arbitrage
Connecticut
$5K – – –
RCM
10
Rivernorth Capital Management
Florida
$5K – – –
CF
11
Cantor Fitzgerald
New York
$4K – – –
PC
12
Periscope Capital
Ontario, Canada
$4K – – –
SCM
13
Shaolin Capital Management
Florida
$4K – – –
Walleye Capital
14
Walleye Capital
New York
$4K +$1.6K +21,351 +25%
Walleye Trading
15
Walleye Trading
New York
$3K +$1.05K +14,000 +24%
HF
16
HRT Financial
New York
$3K +$7.52K +100,115 New
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$2K +$4.57K +60,865 New
SM
18
Skaana Management
New York
$1K -$376 -5,000 -15%
PCM
19
Prelude Capital Management
New York
$1K – – –
SSA
20
Schonfeld Strategic Advisors
New York
$1K +$857 +11,406 New
CL
21
CSS LLC
Illinois
$1K +$1.22K +16,236 New
HHGC
22
Hunting Hill Global Capital
New York
$1K +$1.23K +16,382 New
SIA
23
SkyView Investment Advisors
New Jersey
$1K +$1.51K +20,052 New
LCM
24
Landscape Capital Management
New Jersey
$1K +$2.61K +34,757 New
Citadel Advisors
25
Citadel Advisors
Florida
– -$49K -602,734 Closed
1
2

COEPW Hedge Fund Activity: Q2 2022 in Review

27 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q2 2022, worth a combined $1.03M — down 10% from $1.15M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new COEPW positions and 3 closed out — a net gain of 8 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Meteora Capital, opening a new position worth an estimated $29.2K. The largest seller was Citadel Advisors, exiting entirely with an estimated $49K sold.

  • 27 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q2 2022, up from 19 in Q1 2022.
  • Funds reported $1.03M of Coeptis Therapeutics Warrants stock for Q2 2022, down 10% quarter-over-quarter.
  • 11 funds opened new Coeptis Therapeutics Warrants positions in Q2 2022 and 3 closed out, a net change of +8 holders.
  • The largest Coeptis Therapeutics Warrants buyer in Q2 2022 was Meteora Capital, an estimated $29.2K added.
  • The largest Coeptis Therapeutics Warrants seller in Q2 2022 was Citadel Advisors, an estimated $49K sold.

Based on aggregated 13F filings for Q2 2022.